Development of Theranostic for Acute Myeloid Leukemia (AML) targeting activated conformation of integrin i (sic)2

Wadhwa, AnjuAnjuWadhwaBobba, KondapaKondapaBobbaMandal, KamalKamalMandalBidkar, AnilAnilBidkarRaveendran, AthiraAthiraRaveendranJohnson, HaleyHaleyJohnsonHuebner, JuwitaJuwitaHuebnerAlvarez, MarinaMarinaAlvarezWilson, DavidDavidWilsonVanBrocklin, HenryHenryVanBrocklinSeo, YounghoYounghoSeoAdams, Jarrett J.Jarrett J.AdamsSidhu, SachdevSachdevSidhuWitta, ArunArunWittaFlavell, RobertRobertFlavell2025-08-282025-08-282024-06-010161-5505https://d8.irins.org/handle/IITG2025/19116en-USRadiology, Nuclear Medicine & Medical ImagingDevelopment of Theranostic for Acute Myeloid Leukemia (AML) targeting activated conformation of integrin i (sic)2Meeting Abstracthttps://v2.sherpa.ac.uk/id/publication/239041535-566701-06-2024Meeting AbstractWOS:001289165602109